Intissar Haddiya: Can Low-Dose Rivaroxaban Improve Cardiovascular Outcomes in Patients with Advanced CKD?
Intissar Haddiya, Professor of Nephrology at Faculty of Medicine and Pharmacy of Oujda Mohammed First University, shared a post on LinkedIn about a recent article by Raja Ramachandran et al., published in JAMA, adding:
“Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease (Track_Trial)
Can low-dose rivaroxaban improve cardiovascular outcomes in patients with advanced CKD?
In the TRACK randomized trial (1458 patients with CKD stage 4–5, including those on dialysis):
- No reduction in major cardiovascular events (HR 1.09; p=0.46)
- Higher rates of major bleeding (8.8% vs 6.0%)
- Low-dose rivaroxaban did not provide cardiovascular benefit and increased bleeding risk in this high-risk population.”
Title: Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney DiseaseThe TRACK Randomized Clinical Trial
Authors: Sunil V. Badve, Vlado Perkovic, Vivekanand Jha, Raja Ramachandran, Lily Mushahar, Jan Menne, An S. De Vriese, Patrick Rossignol, Adrien Flahault, Maha Al Ammari, Habib Skhiri, Michael Walsh, David Collister, Adrian Liew, Laurent Billot, Severine Bompoint, Anthony Devaux, Min Jun, Enmoore Lin, Aline Ramos da Cruz, Jeffrey T. Ha, John W. Eikelboom, Ahmed Shaman, Meg J. Jardine, Shilpanjali Jesudason, Muh Geot Wong, Craig S. Anderson, Amit X. Garg, Hiddo J. L. Heerspink, Helen Monaghan, Anushka Patel, Patrick B. Mark, David C. Wheeler, Jicheng Lv, Li Zuo, Helen Pilmore, Martin Gallagher
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 4, 2026, 09:27Hilly Paige: What ESC 2026 Taught Us About LDL-C Management
-
Sep 4, 2026, 05:38Faizan Khan: Why Common Exposures Matter in VTE Risk
-
Sep 4, 2026, 04:56Marwa Mostafa: Microcytosis Is Not Always Iron Deficiency
-
Sep 4, 2026, 03:18Mukesh Kumar Maurya: Beyond ‘aPL Thrombosis’ – A Modern Approach to APS
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia